Filing Details
- Accession Number:
- 0001415889-24-010901
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-16 18:00:52
- Reporting Period:
- 2024-04-15
- Accepted Time:
- 2024-04-16 18:00:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1211583 | Fennec Pharmaceuticals Inc. | FENC | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1717425 | Adrian Haigh | C/O Fennec Pharmaceuticals, Inc. Po Box 13628, 68 Tw Alexander Drive Research Triangle Park NC 27709 | Chief Operating Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares | Acquisiton | 2024-04-15 | 22,222 | $2.31 | 22,222 | No | 4 | S | Direct | |
Common Shares | Acquisiton | 2024-04-16 | 22,222 | $2.31 | 44,444 | No | 4 | S | Direct | |
Common Shares | Disposition | 2024-04-15 | 22,222 | $10.30 | 22,222 | No | 4 | S | Direct | |
Common Shares | Disposition | 2024-04-16 | 22,222 | $10.28 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Options | Common Shares | Disposition | 2024-04-15 | 22,222 | $2.31 | 22,222 | $2.31 |
Options | Common Shares | Disposition | 2024-04-16 | 22,222 | $2.31 | 22,222 | $2.31 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
471,357 | 2014-04-25 | 2024-04-25 | No | 4 | M | Direct |
449,135 | 2014-04-25 | 2024-04-25 | No | 4 | M | Direct |
Footnotes
- Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023.
- Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023.
- Shares disposed pursuant to a 10b5-1 plan dated August 17, 2023.
- Shares acquired pursuant to a 10b5-1 plan dated August 17, 2023.
- Option exercise made pursuant to a 10b5-1 plan dated August 17, 2023.
- Option exercise made pursuant to a 10b5-1 plan dated August 17, 2023.